| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 81,554 | 78,561 | 78,574 | 75,189 | | Cost of Revenue | 37,452 | 42,024 | 43,318 | 38,167 | | | Gross Profit | 44,102 | 36,537 | 35,256 | 37,022 | | | Operating Expenses | | Research Development | 20,361 | 21,283 | 25,384 | 20,739 | | Selling General and Administrative | 31,686 | 33,982 | 34,379 | 28,409 | | Non Recurring | 226 | 1,967 | 253,726 | 19,671 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,171) | (20,695) | (278,233) | (31,797) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,597 | 366 | 3,799 | 1,672 | | Earnings Before Interest And Taxes | 10,632 | (21,535) | (274,434) | (30,125) | | Interest Expense | 2,903 | 3,177 | 3,457 | 3,497 | | Income Before Tax | 7,729 | (24,712) | (277,891) | (33,622) | | Income Tax Expense | 409 | 493 | 40,825 | (1,802) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,320 | (25,205) | (318,716) | (31,820) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,320 | (25,205) | (318,716) | (31,820) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,320 | ($25,205) | ($318,716) | ($31,820) |
|
0.17% Nasdaq 
Income Statement
